Suprasorb H creates an ideal moist wound environment for lightly to moderately exuding wounds, reliably promoting wound healing.
An absorbent hydrocolloid layer which is applied to a polyurethane film swells on contact with the wound to form a gel which binds to the exudate and tissue debris. This gel formation enables the dressing to mould itself to the wound structure. All Suprasorb H versions are especially thin and flexible. It is simple and safe to use because of its excellent adhesive properties. Because the dressing repels both bacteria and fluids, patients can wash and shower easily. Suprasorb H thin is available in a 5 x 5 cm size specifically for the treatment of diabetic foot.
- The hydrocolloid swells when the exudate is absorbed, forming a gel which binds to the exudate and tissue debris.
- repels bacteria and fluids
- Excessive water vapour evaporates.
Dressing Change Interval
Is determined by the treating physician based on wound condition, degree of exudate and possible primary dressing, after 5-7 days at the latest. The dressing must be changed if there is severe blistering extending beyond the wound surface.
|Size (cm)||REF||Shipping Units (pcs.)||Weight in kg (SC/TC)|
|10 x 10||20403||10/660||0.16/10.88|
|15 x 15||20401||5/50||0.23/2.40|
|20 x 20||20402||5/50||0.36/3.80|
|5 x 5||20424||10/1650||0.03/5.88|
|5 x 10||20410||10/480||0.07/3.40|
|5 x 20||20411||10/250||0.13/3.30|
|10 x 10||20412||10/720||0.12/8.71|
|15 x 15||20413||5/50||0.14/1.50|
|20 x 20||20414||5/50||0.23/2.40|
|14 x 16||20430||5/200||0.21/8.80|
|14 x 14||20420||5/200||0.18/7.40|
Clinical efficiency of a hydrocolloid wound dressing in the treatment of severe burns in children.
Author: Baindurashvili, A., Brazol, M., Mitrofanova, E., Tsvetaev, E., Melnikov, M. Citation: Poster. European Wound Management Association (EWMA) Lisbon/P, 14 - 16 May 2008. EWMA Journal Supplement (2008) 8 (2): 179. Type: Clinical trial Main Products: Suprasorb® H Supporting Products: Summary: Suprasorb H is effective in the treatment of children with surface burns II and in the treatment of deep burns IIIA-IIID.
Total treatment approach of a diabetic patient with trophic ulcers - a case study
Author: Begma, A.N. Citation: Abstract. European Wound Management Association (EWMA) Copenhagen/DK, 15.-17. May 2013. EWMA Journal supplement (2013) 13 (1): 207 Type: Case series reports Main Products: Suprasorb® H Supporting Products: Summary: Case study of 68-year-old female patient suffering from diabetes type 1 and a history of cerebral vascular accident. Worsening ulcer on her anterolateral right leg since 2010. A hydrogel was applied on the black necrosis and an alginate covered the rest of the ulcer. A film was used as a secondary dressing. Dressing changes were every two days. After 9 days slough had reduced to 28% of the ulcer surface. Complete wound bed preparation achieved after three weeks.
The after care of medical tattoos
Author: Kuijper-Kuip, E. Citation: Abstract. European Wound Management Association (EWMA) Copenhagen/DK, 15.-17. May 2013. EWMA Journal supplement (2013) 13 (1): 255 Type: Case series reports Main Products: Suprasorb® H Supporting Products: Summary: Over the past 5 years, the author performed 280 medical tattoos of which n=232 were areolas with n=28 on both breasts. Standard care: A thin hydrocolloid (Suprasorb H or Suprasorb F) covered with a film dressing, left in place between 5 and 7 days. No infections were reported and in n=4 the dressing had to be changed. Patients reported the dressing to be comfortable and were allowed to shower with the dressing in place.